Aromasin and cerebral infarction Patient Reports February 11, 2012

Aromasin Side Effects Report #5096546-6
Aromasin side effect was reported by a Physician from INDIA on Aug 17, 2006. Female patient, 70 years of age, was diagnosed with breast cancer female and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: 25 MG (25 MG, 1 IN 1 D); ORAL. Patient recovered.

Aromasin Side Effects Report #5141816-6
Aromasin side effect was reported by a Physician from INDIA on Oct 17, 2006. Female patient, 70 years of age, was diagnosed with breast cancer female and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: 25 MG (25 MG, 1 IN 1 D) ORAL. Patient recovered.

Aromasin Side Effects Report #5795670-X
Aromasin side effect was reported by a Consumer or non-health professional from JAPAN on June 25, 2008. Female patient, 80 years of age, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: unknown. Patient recovered.

Aromasin Side Effects Report #5803910-3
Aromasin side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2008. Female patient, 80 years of age, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: unknown. Patient recovered.


Aromasin Side Effects Report #5093317-1
Aromasin side effect was reported by a Physician from NETHERLANDS on Aug 15, 2006. Female patient, 72 years of age, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood glucose increased, cerebral infarction, high density lipoprotein increased, nuclear magnetic resonance imaging brain abnormal. Aromasin dosage: 25 MG (25 MG, DAILY), ORAL. Patient recovered.

Aromasin Side Effects Report #5097563-2
Aromasin side effect was reported by a Health Professional from NETHERLANDS on Aug 23, 2006. Female patient, 72 years of age, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood glucose increased, cerebral infarction, high density lipoprotein increased. Aromasin dosage: 25 (25 MG, DAILY), ORAL. Patient recovered.

Aromasin Side Effects Report #5121080-4
Aromasin side effect was reported by a Physician from NETHERLANDS on Sept 19, 2006. Female patient, 72 years of age, weighting 224.9 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood glucose increased, central nervous system lesion, cerebral infarction, dizziness , gait disturbance, headache , hypoaesthesia oral, sensory loss. Aromasin dosage: 25 MG (25 MG, DAILY), ORAL. During the same period patient was treated with ASPIRIN, METFORMIN, CARDURA, AMITRIPTYLINE, CHLORTHALIDONE, ENALAPRIL MALEATE. Patient recovered.

Aromasin Side Effects Report #5065389-1
Aromasin side effect was reported by a Physician from INDIA on July 12, 2006. Female patient, 70 years of age, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: 25 MG (25 MG, 1 IN 1 D) ORAL. Patient recovered.

Aromasin Side Effects Report #5141817-8
Aromasin side effect was reported by a Physician from INDIA on Oct 17, 2006. Female patient was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: 25 MG (25 MG, 1 IN 1 D) ORAL. Patient recovered.


Aromasin Side Effects Report #5799234-3
Aromasin side effect was reported by a Physician from JAPAN on June 24, 2008. Female patient, weighting 121.3 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction, muscular weakness. Aromasin dosage: unknown. During the same period patient was treated with CRESTOR, MYSLEE, FOSAMAX, ALFA D, LENDORMIN, NU LOTAN, PAXIL, NAUZELIN. Patient recovered.

Aromasin Side Effects Report #6072458-6
Aromasin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2009. Female patient, weighting 152.1 lb, was diagnosed with breast cancer , hypertension and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: 25 MG, 1X/DAY. During the same period patient was treated with ATENOLOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5766012-0
Aromasin side effect was reported by a Physician from JAPAN on May 30, 2008. Female patient, 68 years of age, was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction. Aromasin dosage: unknown. During the same period patient was treated with CRESTOR, MYSLEE. Patient recovered.

Aromasin Side Effects Report #5072485-1
Aromasin side effect was reported by a Pharmacist from JAPAN on July 20, 2006. Female patient, 53 years of age, was treated with Aromasin. After drug was administered, patient experienced the following side effects: cerebral infarction, multiple sclerosis . Aromasin dosage: 25 MG (25 MG, 1 IN 1 D), ORAL. Patient recovered.

Aromasin Side Effects Report #5080849-5
Aromasin side effect was reported by a Physician from JAPAN on July 31, 2006. Female patient, 53 years of age, was treated with Aromasin. After drug was administered, patient experienced the following side effects: brain stem syndrome, cerebral infarction, demyelination, multiple sclerosis , stress . Aromasin dosage: 25 MG (25 MG, 1 IN 1 D), ORAL. Patient recovered.